<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02272621</url>
  </required_header>
  <id_info>
    <org_study_id>CMILE-C</org_study_id>
    <nct_id>NCT02272621</nct_id>
  </id_info>
  <brief_title>Surgical Trauma After Partial Upper Hemisternotomy Versus Full Sternotomy Aortic Valve Replacement</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single-center, open-label, randomized controlled trial. Patients scheduled for
      aortic valve replacement (AVR) at Karolinska University Hospital in Stockholm, Sweden will be
      eligible. Twenty patients will be randomly assigned to either partial upper sternotomy (20
      patients) or full sternotomy AVR (20 patients). Inclusion criteria is severe aortic stenosis
      referred for medically indicated isolated aortic valve replacement. Exclusion criteria are
      left ventricular ejection fraction less than 0.45, previous cardiac surgery, or
      urgent/emergent surgery.

      CE-marked and FDA-approved mechanical and bioprosthetic (stented or sutureless) aortic valves
      will be implanted. Cytokine release will be repeatedly assessed preoperatively and
      postoperatively (at 0, 6, 12, 18, 24 hours, and 3 days after surgery). Clinical
      characteristics will be registered. Clinical postoperative ouytcomes will be registered.
      Routine blood sampling will be performed pre- and postoperatively. All available data will be
      collected prospectively. Informed consent will be obtained from patients meeting the
      inclusion criteria before the initiation of any study-specific procedures.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Interleukin-6</measure>
    <time_frame>Postoperatively at 0-3 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Interleukin-8</measure>
    <time_frame>Postoperatively at 0-3 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Interleukin-10</measure>
    <time_frame>Postoperatively at 0-3 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Tumor necrosis factor-alpha</measure>
    <time_frame>Postoperatively at 0-3 days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <condition>Heart Valve Diseases</condition>
  <arm_group>
    <arm_group_label>Partial upper hemisternotomy aortic valve replacement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Partial upper hemisternotomy AVR will be performed according to current standard of care practices.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Full sternotomy aortic valve replacement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Full sternotomy AVR through a standard median sternotomy will be performed according to current standard of care practices.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Minimally invasive aortic valve replacement</intervention_name>
    <arm_group_label>Partial upper hemisternotomy aortic valve replacement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Full sternotomy aortic valve replacement</intervention_name>
    <arm_group_label>Full sternotomy aortic valve replacement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ≥ 18 years of age

          -  Severe aortic stenosis defined as aortic valve area of less than 1 cm2 or index area
             of 0.6 cm2/m2 by echocardiography

          -  Referred for medically indicated aortic valve replacement

          -  Sinus rhythm

          -  Provide written informed consent

        Exclusion Criteria:

          -  Left ventricular ejection fraction less than 0.45

          -  Presence of any coexisting severe valvular disorder

          -  Previous cardiac surgery

          -  Urgent or emergent surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Peter Svenarud, MD, PhD</last_name>
    <phone>+46 (0) 8 517 708 12</phone>
    <email>peter.svenarud@karolinska.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Cardiothoracic Surgery and Anesthesiology, Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Svenarud, MD, PhD</last_name>
      <phone>+46 (0) 8 517 708 12</phone>
      <email>peter.svenarud@karolinska.se</email>
    </contact>
    <investigator>
      <last_name>Peter Svenarud, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Magnus Dalén, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ulrik Sartipy, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anders Franco-Cereceda, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mikael Kastengren, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 21, 2014</study_first_submitted>
  <study_first_submitted_qc>October 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 23, 2014</study_first_posted>
  <last_update_submitted>July 17, 2017</last_update_submitted>
  <last_update_submitted_qc>July 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska University Hospital</investigator_affiliation>
    <investigator_full_name>Magnus Dalén</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

